TestEasy
Neurodegenerative Disease Testing
Neurodegenerative Disease Testing
Couldn't load pickup availability
1. Abstract
Understanding your genetic predisposition to health risks is a powerful tool for prevention and personalized healthcare. Genetic analysis can uncover insights into your likelihood of developing various diseases, such as Neurodegenerative Disease. This test explores how health risk analysis based on your genetic makeup can guide proactive health strategies, early interventions, and tailored medical care to improve long-term health outcomes.
2. Background
Why do some people seem to develop certain diseases despite leading a healthy lifestyle, while others remain unaffected? The answer often lies in our genes. Genetics play a key role in determining your risk for conditions like neurodegenerative disease, heart disease, diabetes, and even certain cancers. Health risk analysis through genetic testing allows you to identify your predisposition to these conditions and take steps to prevent them before they manifest.
While we cannot change our genes, understanding your genetic risks allows you to make informed decisions about your lifestyle and healthcare. Armed with this knowledge, you can tailor your diet, exercise, and medical screenings to reduce the likelihood of developing these conditions and live a healthier, longer life.
3. Technology Overview
· SNP Analysis: Single Nucleotide Polymorphisms (SNPs) are small variations in your DNA that can influence how likely you are to develop certain diseases. Genetic testing identifies these SNPs and maps them to known health risks based on large scale genome-wide association studies (GWAS).
· Polygenic Risk Scores: For complex diseases like heart disease or diabetes, multiple genes contribute to the overall risk. Polygenic risk scores aggregate the effects of many genetic variants to give you a clearer picture of your total risk.
· Predictive Health Models: By combining your genetic data with environmental and lifestyle factors, predictive models provide a more comprehensive view of your potential health outcomes. This holistic approach enables more accurate risk predictions and tailored preventive measures.
4. Key Findings
· Neurological Disorders: Genes like APOE (specifically the APOE-e4 variant) have been linked to Alzheimer’s disease. If you are at higher genetic risk for neurodegenerative conditions, early cognitive screenings and lifestyle adjustments (like brain-boosting diets and mental exercises) can help delay or reduce the severity of symptoms.
5. Applications
· Personalized Preventive Healthcare: By understanding your genetic risks, you can take proactive steps to manage your health. Whether it’s regular screenings, lifestyle modifications, or medications, you can work with healthcare providers to create a personalized plan aimed at reducing your specific health risks.
· Early Detection: Genetic testing can identify your predisposition to diseases long before symptoms appear. Early detection allows for timely interventions, such as increasing screening frequency or making dietary and exercise adjustments, to catch potential problems before they become serious.
All 6.4 billion letters of your DNA — read, stored, and yours to keep.
Most consumer DNA tests sample a few hundred thousand positions. Whole genome sequencing reads the entire thing at 30× depth, and hands you the files at the end. No subscription required to keep them.
-
30×
average
coverage depth -
6.4B
base pairs
sequenced -
FASTQ
BAM & VCF
files included
How it runs
Kit arrives
Day 0，Saliva collection takes about five minutes. Avoid eating, drinking, or brushing your teeth for thirty minutes beforehand — that's the only preparation required.
Sample ships back
Day 1–2， Prepaid return envelope is included. Saliva samples are stable at room temperature, so there's no cold chain to manage on your end.
DNA extraction and quality check
Week 1，We extract and assess DNA quality before sequencing. If a sample fails QC, we send a replacement kit at no charge rather than sequencing something that won't yield reliable calls.
Sequencing and analysis
Week 2–6，Sequencing, alignment to GRCh38, and variant calling. This is the longest stage and we'd rather state it accurately than quote a number we miss.
Reports and files released
Week 2–6， Your reports and all three file formats become available together. You'll get an email the moment they're ready.
No. Ebogenes whole genome sequencing is offered for research and personal informational use. It is not a diagnostic test, it is not a substitute for clinical genetic testing, and it should not be used to make medical decisions on its own. If a finding concerns you, bring it to a physician or a certified genetic counsellor — that's what the files are for.
Each position in your genome is read approximately thirty times on average. Sequencing makes errors, so reading a position once tells you little; reading it thirty times lets a variant call rest on consensus. 30× is the widely used standard for reliable variant calling — below it, calls get noticeably less dependable.
Our reports flag findings for follow-up; they do not diagnose. A variant of uncertain significance is a flag, not a finding — many are later reclassified as benign. We'd rather tell you plainly that something needs a professional look than dress up an uncertain result as an answer.
Sequencing and storage happen at our Laval, Québec facility. Your data stays in Canada and is subject to Canadian privacy law. We do not sell your genetic data, and we do not share it with insurers, employers, or research programmes without your explicit, separate consent. You can request deletion at any time.
No. Your reports and all three file formats remain accessible without any ongoing payment. Download them and store your own copy if you prefer — that's the point of giving you FASTQ.